Neuraminidase immunotherapy of tumors in man.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001500:BCG Vaccine; D001806:Blood Urea Nitrogen; D001943:Breast Neoplasms / Q000276:immunology / Q000628:therapy; D002452:Cell Count; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007111:Immunity, Cellular; D007136:Immunoglobulins / Q000302:isolation & purification; D007167:Immunotherapy; D007958:Leukocyte Count; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000628:therapy; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D009439:Neuraminidase / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D014734:Vibrio cholerae / Q000201:enzymology
D001500:BCG Vaccine; D006454:Hemoglobins; D007136:Immunoglobulins; D000410:Alanine Transaminase; D009439:Neuraminidase